The Reason Prescription Drugs Will Never Be Developed Fast!

The video explores the development of Sotorasib, a lung cancer drug targeting KRAS mutations. It covers the drug's journey from basic research in the 1980s to its FDA approval in 2021. The process includes understanding KRAS gene mutations, developing molecules to inhibit mutant proteins, and conducting clinical trials. The video highlights the importance of thorough research and development in creating effective cancer treatments.

What new insight or understanding did you gain from this video?